Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Hydrogen water to reduce fatigue and improve function in ME/CFS

Official title: Heart Rate Variability as an Autonomic Marker of Improvement in ME/CFS in a Hydrogen Water Treatment Study

Run by Stony Brook University · NCT07009691 · Data updated 2026-11-12

This project will try hydrogen water in adults with ME/CFS to see if it reduces fatigue and improves function and whether heart rate variability can predict who benefits.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment50 (estimated)
SponsorStony Brook University
Academic / other
Locations1 site (Stony Brook, New York)
StatusRecruiting
StartedJune 9, 2025
Main results expectedMay 31, 2026
Study endsMay 31, 2026
Registry record updatedJune 8, 2025
Trial IDNCT07009691 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults who meet the Institute of Medicine criteria for ME/CFS, whose fatigue is not explained by another medical illness, and who do not have psychosis are ideal candidates.

Probably not a fit

People whose fatigue is due to another diagnosed medical condition or who have active psychosis are unlikely to benefit and would be excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot interventional study enrolls adults with ME/CFS and gives hydrogen water made from an over-the-counter magnesium-based supplement using a 10-day graduated dosing schedule followed by a standard daily dose for 16 weeks. Participants will be monitored for changes in fatigue-related symptoms and physical functioning, and heart rate variability (HRV) will be measured as a candidate biomarker. Investigators plan to identify two outcome subgroups—improvers and non-improvers—and test whether higher baseline HRV predicts clinical improvement. The single-site study at Stony Brook University is intended to generate preliminary data to guide larger trials.

Why it matters

Potential benefit: If successful, hydrogen water could reduce fatigue and increase physical function for some people with ME/CFS.

How similar studies have gone: Prior clinical evidence for hydrogen water in ME/CFS is limited, and using HRV as a predictive biomarker in this condition is largely novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria: Meets Institute of Medicine criteria for myalgic encephalomyelitis/chronic fatigue syndrome -

Exclusion Criteria: Medical illness that explains presenting fatigue; Any psychosis.

\-

Where it's running

  • Stony Brook University
    Stony Brook, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.